ScholarWorks@Korea University

Browsing by Hou, JinlinAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 4 of 4

SCIESCOPUS
Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions

Ahn, Sang Hoon; Chan, Henry L. Y.; Chen, Pei-Jer; Cheng, Jun; Goenka, Mahesh K.; Hou, Jinlin; Lim, Seng Gee; Omata, Masao; Piratvisuth, Teerha; Xie, Qing, et al.

ArticleIssue Date2010CitationHEPATOLOGY INTERNATIONAL, v.4, no.1, pp 386 - 395PublisherSPRINGER
SCIESCOPUS
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection

Yuen, Man-Fung; Lim, Seng-Gee; Plesniak, Robert; Tsuji, Keiji; Janssen, Harry L. A.; Pojoga, Cristina; Gadano, Adrian; Popescu, Corneliu P.; Stepanova, Tatyana; Asselah, Tarik, et al.

ArticleIssue Date2022CitationNEW ENGLAND JOURNAL OF MEDICINE, v.387, no.21, pp 1957 - 1968PublisherMASSACHUSETTS MEDICAL SOC
SCIESCOPUS
Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy

Yuen, Man-Fung; Heo, Jeong; Kumada, Hiromitsu; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Xie, Qing; Jia, Jidong; Karino, Yoshiyasu; Hou, Jinlin; Chayama, Kazuaki, et al.

ArticleIssue Date2022CitationJOURNAL OF HEPATOLOGY, v.77, no.4, pp 967 - +PublisherELSEVIER
SCISCIESCOPUS
RESULTS AFTER 12 WEEKS TREATMENT OF MULTIPLE DOSES OF GSK3389404 IN CHRONIC HEPATITIS B (CHB) SUBJECTS ON STABLE NUCLEOS(T)IDE THERAPY IN A PHASE 2a DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Yuen, Man-Fung; Heo, Jeong; Kumada, Hiromitsu; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Xie, Qing; Jia, Jidong; Karino, Yoshiyasu; Hou, Jinlin; Chayama, Kazuaki, et al.

ArticleIssue Date2019CitationHEPATOLOGY, v.70, pp 433A - 434APublisherWILEY
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

COPYRIGHT © 2021 Korea University. All Rights Reserved.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어